The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care
Author:
- 28 October 2020
- journal article
- other
- Published by Taylor & Francis in Expert Review of Precision Medicine and Drug Development
- Vol. 6 (1) , 51-63
Abstract
In parallel to the clinical maturation of heart transplantation over the last 50 years, rejection testing has been revolutionized within the systems biology paradigm triggered by the Human Genome P...Keywords
This publication has 105 references indexed in Scilit:
- The multidimensional perspective of cardiac allograft rejectionCurrent Opinion in Organ Transplantation, 2013
- Circulating miRNAs reflect early myocardial injury and recovery after heart transplantationJournal of Cardiothoracic Surgery, 2013
- Computational Biomarker Pipeline from Discovery to Clinical Implementation: Plasma Proteomic Biomarkers for Cardiac TransplantationPLOS Computational Biology, 2013
- Differential Expression of MicroRNAs During Allograft RejectionAmerican Journal of Transplantation, 2012
- Universal noninvasive detection of solid organ transplant rejectionProceedings of the National Academy of Sciences, 2011
- Molecular Testing for Long-term Rejection Surveillance in Heart Transplant Recipients: Design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) TrialThe Journal of Heart and Lung Transplantation, 2007
- Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression ProfilingAmerican Journal of Transplantation, 2005
- Initial sequencing and analysis of the human genomeNature, 2001
- T-CELL AND MONOCYTE SUBSETS, INFLAMMATORY MOLECULES, REJECTION, AND HEMODYNAMICS EARLY AFTER CARDIAC TRANSPLANTATION1Transplantation, 1998
- Early diastolic left ventricular function as a marker of acute cardiac rejection: a prospective serial echocardiographic studyInternational Journal of Cardiology, 1992